RxDoctor Payments Data

Vincent Dinapoli

Neurological Surgery · Cincinnati, OHNPI 1144482746

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.6%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 38.4% of the total. Reporting peaked in 2024 at $4,399 and has fallen 63.9% since, to $1,590 in 2025.

$7,166in general payments, 2019–2025

Across 79 payments — averaging $90.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$3K
  • Johnson & Johnson$2K
  • Globus Medical$1K
  • GT Medical Technologies, Inc$406
  • Integra Lifesciences Corporation$202
  • Highridge Medical LLC$175
  • plus $609 from 8 others
$184,422in research payments, 2019–2025

Across 14 payments — averaging $13,173 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GT Medical Technologies, Inc$184K

What the payments were for

  • Travel & lodging$3,18044%
  • Food & beverage$3,91455%
  • Gifts$721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,166 in reported general payments places this provider in the 65th percentile of 301 neurological surgery providers in Ohio.

See all neurological surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$271,499
Medicare patients
258
Services billed
893

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam23$476
Methylprednisolone26$221
Gabapentin26$192
Carbamazepine12$134

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →